IGV-001 Archives - American Brain Tumor Association

The 2024 Impact Report is here! Your support is powering progress: Read the full report

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Subscribe to MindMatters

Imvax researcher in lab

Imvax Advances a New Approach to Personalized Cancer Immunotherapy

**Sponsored Content**

Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.

Share:

More Posts

Dr Michael Olin Immunitherapy

Bringing New Hope: Dr. Michael Olin’s Breakthrough Immunotherapy for Brain Tumors

Mental Health Tips for Brain Tumor Caregivers: How to Cope and Recharge

Mental Health Tips for Brain Tumor Caregivers: How to Cope and Recharge

How to Protect Your Mental Health While Living with a Brain Tumor Diagnosis

How to Protect Your Mental Health While Living with a Brain Tumor Diagnosis

Beth Kassab

Beth Kassab: Finding Connection After a Brain Tumor Diagnosis

what is scanxiety?

What Is Scanxiety?

What If My Brain Tumor Comes Back? How to Prepare Emotionally and Medically

What If My Brain Tumor Comes Back? How to Prepare Emotionally and Medically

Popular Posts

Researchers Recognized for Population Studies on Brain Tumors

ABTA Partners with National Cancer Institute to Accelerate Rare Brain Tumor Treatment and Research

MindMatters | March 2020

Walking 1,000+ Miles for His Best Friend

This Fall, BT5K Your Way

2022 National Conference speaker Liz Salmi

Top Takeaways from the 2022 National Conference

Popular Topics

Upcoming Events

Educational Resources

Always free for patients & caregivers